 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 January 1994 | Volume 120 Issue 1 | Pages 26-34
Objective: To describe mortality over 15 years in a cohort of patients with rheumatoid arthritis, according to a simple questionnaire and joint count.
Design: A cohort study with 15 years of follow-up.
Setting: University hospital outpatient clinic.
Patients: A cohort of 75 patients with rheumatoid arthritis.
Measurements: Quantitative baseline measures: demographic, articular (joint counts), clinical, questionnaire, and physical measures, including modified questionnaire and joint count measures with substantially fewer items.
Results: Although few deaths were seen in the first 3 years after baseline, the standard mortality ratio over 15 years was 1.62, similar to findings in other series. Significant predictors of mortality included age, formal education level, joint count, activities-of-daily-living questionnaire scores, disease adjustment scores, morning stiffness, comorbid cardiovascular disease, grip strength, modified walking time, and button test. Five-year survival in patients with the poorest status according to these quantitative measures was 40% to 60%, comparable to expected survival at that time of patients with three-vessel coronary artery disease or with stage 4 Hodgkin disease. Simplified measures, including a count using only 28 joints and a questionnaire using only 8 activities of daily living, were similar to the more elaborate traditional measures for predicting mortality.
Conclusion: Higher mortality rates in patients with rheumatoid arthritis are predicted by more severe clinical disease, as in other chronic diseases. Severe rheumatoid arthritis may be identified using quantitative functional status questionnaires and joint counts, which can be ascertained in about 10 to 15 minutes in any clinical setting.
Author and Article Information
From Vanderbilt University School of Medicine, Nashville, Tennessee.
ARTICLE
Prediction of Long-Term Mortality in Patients with Rheumatoid Arthritis according to Simple Questionnaire and Joint Count Measures
Requests for Reprints: Theodore Pincus, MD, Vanderbilt University School of Medicine, Department of Medicine, Division of Rheumatology and Immunology, T-3219 Medical Center North, Nashville, TN 37232.
Acknowledgments: The authors thank Stewart B. Marcum, Annette M. Oeser, and Brigitta Brannon for helpful technical support; and Dr. David Felson for helpful comments.
Grant Support: The Jack C. Massey Foundation, Sandoz Pharma Ltd., grant AM-21393 from the National Institutes of Health to the American Rheumatism Association Medical Information System, and grant 5M01RR-0095 from the National Institutes of Health General Clinical Research Centers.
This article has been cited by other articles:
|
|
 |
|
  D Aletaha, V Strand, J S Smolen, and M M Ward Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results Ann Rheum Dis, February 1, 2008; 67(2): 238 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brenner, T. Laragione, A. Mello, and P. S Gulko Cia25 on rat chromosome 12 regulates severity of autoimmune arthritis induced with pristane and with collagen Ann Rheum Dis, July 1, 2007; 66(7): 952 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M Farragher, M. Lunt, D. K Bunn, A. J Silman, and D. P M Symmons Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register Ann Rheum Dis, April 1, 2007; 66(4): 486 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Turesson, R L McClelland, T J H Christianson, and E L Matteson Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis Ann Rheum Dis, January 1, 2007; 66(1): 70 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Turesson, R L McClelland, T J H Christianson, and E L Matteson Multiple extra-articular manifestations are associated with poor survival in patients with rheumatoid arthritis. Ann Rheum Dis, November 1, 2006; 65(11): 1533 - 1534. [Full Text] [PDF]
|
|
|
|
 |
|
 D Aletaha, K. P. Machold, V. P. K. Nell, and J. S. Smolen The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey Rheumatology, September 1, 2006; 45(9): 1133 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Pincus, T Sokka, C P Chung, and G Cawkwell Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials Ann Rheum Dis, July 1, 2006; 65(7): 878 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Kavanaugh Health economics: implications for novel antirheumatic therapies Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv65 - iv69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Escalante, R. W. Haas, and I. del Rincon Paradoxical Effect of Body Mass Index on Survival in Rheumatoid Arthritis: Role of Comorbidity and Systemic Inflammation Arch Intern Med, July 25, 2005; 165(14): 1624 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Turesson, L. Jacobsson, A. Ryden Ahlgren, G. Sturfelt, P. Wollmer, and T. Lanne Increased stiffness of the abdominal aorta in women with rheumatoid arthritis Rheumatology, July 1, 2005; 44(7): 896 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J S Smolen In the middle of the decade Ann Rheum Dis, June 1, 2005; 64(6): 797 - 797. [Full Text] [PDF]
|
|
|
|
|
|
Y Yazici, T Sokka, H Kautiainen, C Swearingen, I Kulman, and T Pincus Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities Ann Rheum Dis, February 1, 2005; 64(2): 207 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Pincus and T Sokka Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa? Ann Rheum Dis, November 1, 2004; 63(suppl_2): ii32 - ii39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Turesson, A Jarenros, and L Jacobsson Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study Ann Rheum Dis, August 1, 2004; 63(8): 952 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F C Breedveld and J R Kalden Appropriate and effective management of rheumatoid arthritis Ann Rheum Dis, June 1, 2004; 63(6): 627 - 633. [Abstract] [Full Text]
|
|
|
|
|
|
E. L. Matteson, C. M. Weyand, J. W. Fulbright, T. J. H. Christianson, R. L. McClelland, and J. J. Goronzy How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial Rheumatology, May 1, 2004; 43(5): 619 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Smyth, A. J. MacGregor, D. Mukerjee, G. M. Brough, C. M. Black, and C. P. Denton A cross-sectional comparison of three self-reported functional indices in scleroderma Rheumatology, June 1, 2003; 42(6): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Brod Ingested Type I Interferon: State of the Art as Treatment for Autoimmunity Experimental Biology and Medicine, December 1, 2002; 227(11): 981 - 988. [Abstract] [Full Text]
|
|
|
|
|
|
T R Mikuls, K G Saag, L A Criswell, L A Merlino, R A Kaslow, B J Shelton, and J R Cerhan Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study Ann Rheum Dis, November 1, 2002; 61(11): 994 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Peltomaa, L Paimela, H Kautiainen, and M Leirisalo-Repo Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis Ann Rheum Dis, October 1, 2002; 61(10): 889 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Burt, S. Slavin, W. H. Burns, and A. M. Marmont Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood, February 1, 2002; 99(3): 768 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pincus, T. Sokka, and C. M. Stein Are Long-Term Very Low Doses of Prednisone for Patients with Rheumatoid Arthritis as Helpful as High Doses Are Harmful? Ann Intern Med, January 1, 2002; 136(1): 76 - 78. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bhandari, G. H. Guyatt, and M. F. Swiontkowski User's Guide to the Orthopaedic Literature: How to Use an Article About Prognosis J. Bone Joint Surg. Am., October 1, 2001; 83(10): 1555 - 1564. [Full Text] [PDF]
|
|
|
|
 |
|
 C E Dionne, M Von Korff, T D Koepsell, R A Deyo, W E Barlow, and H Checkoway Formal education and back pain: a review J Epidemiol Community Health, July 1, 2001; 55(7): 455 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D HUTCHINSON, R J MOOTS;, H A CAPELL, N MAIDEN, R MADHOK, R HAMPSON, and E A THOMSON Diagnostic evaluation of classification criteria for RA and reactive arthritis. Ann Rheum Dis, May 1, 2000; 59(5): 396 - 397. [Full Text]
|
|
|
|
|
|
T. Sokka, T. Mottonen, and P. Hannonen Disease-modifying anti-rheumatic drug use according to the `sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature Rheumatology, January 1, 2000; 39(1): 34 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Burt and A. E. Traynor Hematopoietic Stem Cell Transplantation: A New Therapy for Autoimmune Disease Stem Cells, November 1, 1999; 17(6): 366 - 372. [Full Text]
|
|
|
|
 |
|
 R. K. Burt and A. E. Traynor Hematopoietic Stem Cell Transplantation: A New Therapy for Autoimmune Disease Oncologist, February 1, 1999; 4(1): 77 - 83. [Full Text]
|
|
|
|
|
|
E. Lindqvist and K. Eberhardt Mortality in rheumatoid arthritis patients with disease onset in the 1980s Ann Rheum Dis, January 1, 1999; 58(1): 11 - 14. [Abstract] [Full Text]
|
|
|
|
|
|
J. R O'Dell, B. S Nepom, C. Haire, V. H Gersuk, L. Gaur, G. F Moore, W. Drymalski, W. Palmer, P J. Eckhoff, L. W Klassen, et al. HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments Ann Rheum Dis, April 1, 1998; 57(4): 209 - 213. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. W. Moreland, S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, et al. Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)-Fc Fusion Protein N. Engl. J. Med., July 17, 1997; 337(3): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. O'Dell, C. E. Haire, N. Erikson, W. Drymalski, W. Palmer, P. J. Eckhoff, V. Garwood, P. Maloley, L. W. Klassen, S. Wees, et al. Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications N. Engl. J. Med., May 16, 1996; 334(20): 1287 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tugwell, T. Pincus, D. Yocum, M. Stein, O. Gluck, G. Kraag, R. McKendry, J. Tesser, P. Baker, G. Wells, et al. Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis N. Engl. J. Med., July 20, 1995; 333(3): 137 - 142. [Abstract] [Full Text] [PDF]
|
|
Article
